NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 389 filers reported holding NOVAVAX INC in Q1 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,019 | -2.6% | 417 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $3,098 | +7.2% | 417 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $2,890 | -32.6% | 417 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,287 | -46.4% | 417 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $8,000 | -61.9% | 417 | 0.0% | 0.00% | -60.0% |
| Q2 2022 | $21,000 | -32.3% | 417 | 0.0% | 0.01% | -16.7% |
| Q1 2022 | $31,000 | -48.3% | 417 | 0.0% | 0.01% | -40.0% |
| Q4 2021 | $60,000 | -30.2% | 417 | 0.0% | 0.01% | -37.5% |
| Q3 2021 | $86,000 | -3.4% | 417 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $89,000 | +17.1% | 417 | 0.0% | 0.02% | +14.3% |
| Q1 2021 | $76,000 | +192.3% | 417 | +75.9% | 0.01% | +180.0% |
| Q4 2020 | $26,000 | 0.0% | 237 | 0.0% | 0.01% | -16.7% |
| Q3 2020 | $26,000 | – | 237 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 132,500 | $2,414,000 | 0.77% |
| HAP Trading, LLC | 130,000 | $10,673,000 | 0.71% |
| Mendel Capital Management LLC | 23,835 | $434,000 | 0.51% |
| Faithward Advisors, LLC | 115,912 | $2,109,000 | 0.50% |
| Rock Springs Capital Management LP | 599,300 | $10,907,000 | 0.28% |
| SECTOR GAMMA AS | 56,735 | $1,033,000 | 0.27% |
| Quantitative Investment Management, LLC | 83,072 | $1,511,000 | 0.25% |
| LMR Partners LLP | 396,100 | $7,209,000 | 0.13% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 1,333,706 | $24,273,000 | 0.13% |
| TSP Capital Management Group, LLC | 16,025 | $292,000 | 0.12% |